chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Wheezing
Clinical narrative: Starting 06/18/2022, I had congestion which worsened and then included coughing, wheezing and a fever of 101 for a few days and body aches. I tested positive on 06/18/2022. The body aches were the worst around Tuesday 06/21/2022 to the point where I didn't want to move and my joints hurt a lot as well. My congestion gradually got better up until yesterday. My aches are becoming more infrequent. My fever has resolved. I still have coughing spells and have only needed to use my inhaler 1x or 2x. I have been taking mucinex to help with congestion and staying hydrated. On day 5, I still tested positive. I will go back this coming Tuesday (07/05/2022) and I am still experiencing fatigue, feeling out of breath if I exert myself and coughing spells. I am continuing mucinex to keep the mucous thin so that I don't have trouble breathing. My congestion is not fully resolved but its getting better and the mucinex is helping that. Also, all the food I ate tasted metallic and as of today its better but still present. Also, my face was very sensitive and my normal face wash bothered my skin.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Choking, Dyspnoea, Nausea, Secretion discharge, Sleep disorder
Clinical narrative: She got her vaccine, and noticed that her allergy medicine stopped working they way that it had been.  Her allergy medicine after did not stop her mucous, actually became worse and did not know what to do.  She almost felt like she was choking on her mucous.  She started waking up with choking episodes or mucous and started vomiting.  In order to control her asthma since she has had to take 2 allergy pills versus the one, and still produces a lot of mucous, which should not be happening.   The waking up/choking episodes do not happen as often, but they do still happen.    She does have to do breathing treatments as needed and has had to do them more often since the vaccine.    She went to the UC and they did not give her much to do, told her for the nausea to elevate and nothing given for the increased mucous production.    Wonders if there is any way to reverse the effects as the mucous is bad, the trouble breathing is frightening.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic product effect decreased, Vomiting
Clinical narrative: She got her vaccine, and noticed that her allergy medicine stopped working they way that it had been.  Her allergy medicine after did not stop her mucous, actually became worse and did not know what to do.  She almost felt like she was choking on her mucous.  She started waking up with choking episodes or mucous and started vomiting.  In order to control her asthma since she has had to take 2 allergy pills versus the one, and still produces a lot of mucous, which should not be happening.   The waking up/choking episodes do not happen as often, but they do still happen.    She does have to do breathing treatments as needed and has had to do them more often since the vaccine.    She went to the UC and they did not give her much to do, told her for the nausea to elevate and nothing given for the increased mucous production.    Wonders if there is any way to reverse the effects as the mucous is bad, the trouble breathing is frightening.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: This patient was under the recommended to age to receive the Covid-19 Vaccine on the vaccination date of 1/8/2022.  The child was 3 years old.  I was advised RN  to complete a report on the VAERS system.   This particular vaccination clinic was off site at the local public high school.  The person who vaccinated this child was a Public School Nurse.  The Health Division has not received any notification of this child having any medical problems to date.
Age: 54.0
Sex: F
Vaccine: HEP
Symptoms: Mumps, Musculoskeletal stiffness, Rash, Swelling
Clinical narrative: Also received MUMPS Reaction - stiffness in both hands, rash/bump on chest and one on  left arm
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 57.0
Sex: F
Vaccine: UNK
Symptoms: Injection site pain
Clinical narrative: Injection site pain. Has had pain over injection site started day of vaccination until today (6/28/2022).
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acquired diaphragmatic eventration, Acute respiratory failure, Asthenia, Atrial fibrillation, Blood creatinine increased
Clinical narrative: Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22  1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia.  Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive.  Patient was seen by family physician, was asked to monitor pulse ox.  Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room.  He received monoclonal antibody infusion yesterday.  Patient says he is vaccinated against COVID-19 x2 doses, but no booster.  His friend who lives with him also has mild symptoms.  Denies nausea or vomiting, but had some loose stools.   Per EMS his oxygen saturation was 74% on room air.  In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask.  Blood work shows leukocytosis with neutrophilia and lymphopenia.  Mild hyponatremia and elevated BUN and creatinine noted.  Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect.   Patient was given IV dexamethasone 6 mg in the ED.  1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test abnormal, Blood urea increased, COVID-19, Cardioversion, Chest X-ray abnormal
Clinical narrative: Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22  1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia.  Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive.  Patient was seen by family physician, was asked to monitor pulse ox.  Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room.  He received monoclonal antibody infusion yesterday.  Patient says he is vaccinated against COVID-19 x2 doses, but no booster.  His friend who lives with him also has mild symptoms.  Denies nausea or vomiting, but had some loose stools.   Per EMS his oxygen saturation was 74% on room air.  In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask.  Blood work shows leukocytosis with neutrophilia and lymphopenia.  Mild hyponatremia and elevated BUN and creatinine noted.  Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect.   Patient was given IV dexamethasone 6 mg in the ED.  1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Diarrhoea, Dyspnoea, Endotracheal intubation
Clinical narrative: Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22  1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia.  Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive.  Patient was seen by family physician, was asked to monitor pulse ox.  Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room.  He received monoclonal antibody infusion yesterday.  Patient says he is vaccinated against COVID-19 x2 doses, but no booster.  His friend who lives with him also has mild symptoms.  Denies nausea or vomiting, but had some loose stools.   Per EMS his oxygen saturation was 74% on room air.  In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask.  Blood work shows leukocytosis with neutrophilia and lymphopenia.  Mild hyponatremia and elevated BUN and creatinine noted.  Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect.   Patient was given IV dexamethasone 6 mg in the ED.  1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hyponatraemia, Hypotension, Hypoxia, Leukocytosis, Lung infiltration
Clinical narrative: Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22  1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia.  Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive.  Patient was seen by family physician, was asked to monitor pulse ox.  Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room.  He received monoclonal antibody infusion yesterday.  Patient says he is vaccinated against COVID-19 x2 doses, but no booster.  His friend who lives with him also has mild symptoms.  Denies nausea or vomiting, but had some loose stools.   Per EMS his oxygen saturation was 74% on room air.  In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask.  Blood work shows leukocytosis with neutrophilia and lymphopenia.  Mild hyponatremia and elevated BUN and creatinine noted.  Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect.   Patient was given IV dexamethasone 6 mg in the ED.  1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphopenia, Malaise, Mechanical ventilation, Multiple organ dysfunction syndrome, Neutrophilia
Clinical narrative: Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22  1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia.  Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive.  Patient was seen by family physician, was asked to monitor pulse ox.  Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room.  He received monoclonal antibody infusion yesterday.  Patient says he is vaccinated against COVID-19 x2 doses, but no booster.  His friend who lives with him also has mild symptoms.  Denies nausea or vomiting, but had some loose stools.   Per EMS his oxygen saturation was 74% on room air.  In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask.  Blood work shows leukocytosis with neutrophilia and lymphopenia.  Mild hyponatremia and elevated BUN and creatinine noted.  Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect.   Patient was given IV dexamethasone 6 mg in the ED.  1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pain, Pneumonia bacterial, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22  1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia.  Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive.  Patient was seen by family physician, was asked to monitor pulse ox.  Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room.  He received monoclonal antibody infusion yesterday.  Patient says he is vaccinated against COVID-19 x2 doses, but no booster.  His friend who lives with him also has mild symptoms.  Denies nausea or vomiting, but had some loose stools.   Per EMS his oxygen saturation was 74% on room air.  In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask.  Blood work shows leukocytosis with neutrophilia and lymphopenia.  Mild hyponatremia and elevated BUN and creatinine noted.  Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect.   Patient was given IV dexamethasone 6 mg in the ED.  1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Superinfection
Clinical narrative: Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22  1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia.  Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive.  Patient was seen by family physician, was asked to monitor pulse ox.  Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room.  He received monoclonal antibody infusion yesterday.  Patient says he is vaccinated against COVID-19 x2 doses, but no booster.  His friend who lives with him also has mild symptoms.  Denies nausea or vomiting, but had some loose stools.   Per EMS his oxygen saturation was 74% on room air.  In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask.  Blood work shows leukocytosis with neutrophilia and lymphopenia.  Mild hyponatremia and elevated BUN and creatinine noted.  Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect.   Patient was given IV dexamethasone 6 mg in the ED.  1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.
Age: 1.0
Sex: M
Vaccine: FLU4
Symptoms: Rash
Clinical narrative: Generalized severe rash.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Oedema
Clinical narrative: Both my ankles were very swollen, droopy, and pitting. Kind of like how I sometimes get with certain medications but I hadn't taken anything that would have caused that. And since the vaccine was the only thing I had taken, I looked it up and saw that was a potential reaction. It went away in 4-5 days. I had never seen my ankles that swollen before.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three doses; patient expired  Moderna 1/26/21 Lot#027L20A;  Moderna 2/23/21 Lot# 011M20A;  Moderna 1/7/22 Lot# 030H21B;
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenopia, Dyspnoea, Hyperhidrosis, Tremor, Vertigo
Clinical narrative: 56-year-old female 15 minutes post vaccine (Post Moderna booster vaccine) at 9:30 am client complained of "head spinning", Client stated no history of past vaccine reactions and no history of anxiety. Client states she has eaten this morning. Son used as interpreter. Nurse assisted in assessment of symptoms with blood pressure as first reading, 9:34 am BP: 62/42 RR: 48 HR: 52.  Nurse and son assist client to anti-gravity chair for further assessment and observation.  Client became diaphoretic and shaking. Instructed to deep breathe.  Son gave client (mom) sips of water per her request. 9:39 am, BP: 113/69 HR: 68.  Nurses continued to observe client for additional complications.  Client continues to tremble.  Next set of vital signs during observation: 9:43 am BP: 124/76 HR: 83. Client was given juice, breathing improved and less diaphoretic. Client continues to stay oriented x 4. Vital signs at 9:48 BP: 123/84 HR: 81 RR: 30.  Client verbalizes that she is "feeling better" and eyes feel heavy.  Client states she would like to go home. Last set of vitals before client is sent home: 9:53 am BP: 129/92 HR: 75 RR: 17.  Client left observation area on own steady gait.  Reviewed patient education with son instructing to call emergency services if symptoms return or worsen.
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, MMRV, PNC13
Symptoms: Injection site swelling, Mobility decreased, Pyrexia, Seizure like phenomena
Clinical narrative: Per parent, client developed fever of either 100.5 or 105 degrees. Parent was unsure. Parent states they witnessed convulsive like activity. Parents took child to Hospital ER. Per parent, ER gave child Tylenol. After fever decreased and they were discharged approximately 2 hours after arrival. Today child is not very active. The only other symptom is slight local swelling of thighs.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: PATIENT RECEIVED VACCINE ON 06/15/2022 AND CAME BACK FOR SECOND DOSE BEFORE 21 DAYS. WAS GIVEN SECOND DOSE ON 06/24/2022 BEFORE FILLING OUT CARD AND SEEING DATES
Age: 30.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: COVID-19, Cough, Fatigue, Feeling abnormal, Headache
Clinical narrative: I started getting symptoms of headache, nasal drainage, fever, and sore throat. Then my fever progressed to 101-102 and a cough. I took an at home COVID-19 test and took a PCR COVID-19 test which were positive. I received Paxlovid which I had an allergic reaction to and experienced a rash and hives all over my body. I called my PCP and was told to go to an urgent care. While at urgent care I was given Benadryl and was told not to take Paxlovid. I still have lingering effects of cough, sore throat, headache, tiredness, brain fog, and body aches.
Age: 30.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test positive, Sinus operation
Clinical narrative: I started getting symptoms of headache, nasal drainage, fever, and sore throat. Then my fever progressed to 101-102 and a cough. I took an at home COVID-19 test and took a PCR COVID-19 test which were positive. I received Paxlovid which I had an allergic reaction to and experienced a rash and hives all over my body. I called my PCP and was told to go to an urgent care. While at urgent care I was given Benadryl and was told not to take Paxlovid. I still have lingering effects of cough, sore throat, headache, tiredness, brain fog, and body aches.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Aspartate aminotransferase increased, Asthenia, Blood alkaline phosphatase increased, Blood bilirubin increased
Clinical narrative: Moderna Dose 1 3/29/21 (039A21A) Moderna Dose 2 4/26/21 (048B21A) COVID Positive 1/4/22  1/13/22: Patient is a 71 year old male who presented to ED via EMS with complaints of generalized weakness. Patient has been vaccinated against COVID-19, did not receive his booster. He was seen in ED on 1/4 and tested positive for Covid-19. He was discharged home with the Covid home program. Per chart review the patient was contacted on 1/7 and stated he was "getting better" and would prefer not to participate in the program. Patient stated his symptoms worsened five days after testing positive for Covid. He has been experiencing extreme fatigue, nausea and diarrhea for the past 4 days.  He has been unable to tolerate food or fluids in the past 4 days. He has become progressively short of breath over the past several days. He has a past medical history of hypertension, borderline diabetes, and cirrhosis secondary to alcohol use.   On arrival to ED the patient was hypoxic on room air at 83%, 15 L OxyMask was applied on arrival to ED with improvement oxygen saturations, patient was weaned down to 10 L. laboratory findings were significant for mild hypokalemia 3.6.  Hyperglycemia 151.  Transaminitis AST 57 in ALP 151. Hyperbilirubinemia 1.4.  Lactic acidosis 3.9. PH 7.46 pCO2 32 PO2 67. D-dimer 3.41.  Chest x-ray shows interval worsening with diffuse multifocal bilateral airspace disease.  Azithromycin and ceftriaxone were initiated in ED.  Patient received DuoNeb treatment.  IV hydration was given with NS 0.9% 1 L.  1/20/22: 71-year-old male with no significant past medical history apart from alcohol abuse and liver cirrhosis who presented to the emergency department with shortness of breath admitted for COVID-19 pneumonia.  Pt was started on Rocephin and Zithromax, he received Actemra, no remdesivir due to liver cirrhosis, was on Lovenox twice a day, and Decadron.  Oxygen requirement were high initially but was successfully weaned down to 2 L by nasal cannula. Currently seems to be stable for discharge.  Will discharge to skilled nursing facility per PT/OT evaluation.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood lactic acid, Blood pH increased, Blood potassium normal, COVID-19
Clinical narrative: Moderna Dose 1 3/29/21 (039A21A) Moderna Dose 2 4/26/21 (048B21A) COVID Positive 1/4/22  1/13/22: Patient is a 71 year old male who presented to ED via EMS with complaints of generalized weakness. Patient has been vaccinated against COVID-19, did not receive his booster. He was seen in ED on 1/4 and tested positive for Covid-19. He was discharged home with the Covid home program. Per chart review the patient was contacted on 1/7 and stated he was "getting better" and would prefer not to participate in the program. Patient stated his symptoms worsened five days after testing positive for Covid. He has been experiencing extreme fatigue, nausea and diarrhea for the past 4 days.  He has been unable to tolerate food or fluids in the past 4 days. He has become progressively short of breath over the past several days. He has a past medical history of hypertension, borderline diabetes, and cirrhosis secondary to alcohol use.   On arrival to ED the patient was hypoxic on room air at 83%, 15 L OxyMask was applied on arrival to ED with improvement oxygen saturations, patient was weaned down to 10 L. laboratory findings were significant for mild hypokalemia 3.6.  Hyperglycemia 151.  Transaminitis AST 57 in ALP 151. Hyperbilirubinemia 1.4.  Lactic acidosis 3.9. PH 7.46 pCO2 32 PO2 67. D-dimer 3.41.  Chest x-ray shows interval worsening with diffuse multifocal bilateral airspace disease.  Azithromycin and ceftriaxone were initiated in ED.  Patient received DuoNeb treatment.  IV hydration was given with NS 0.9% 1 L.  1/20/22: 71-year-old male with no significant past medical history apart from alcohol abuse and liver cirrhosis who presented to the emergency department with shortness of breath admitted for COVID-19 pneumonia.  Pt was started on Rocephin and Zithromax, he received Actemra, no remdesivir due to liver cirrhosis, was on Lovenox twice a day, and Decadron.  Oxygen requirement were high initially but was successfully weaned down to 2 L by nasal cannula. Currently seems to be stable for discharge.  Will discharge to skilled nursing facility per PT/OT evaluation.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: Moderna Dose 1 3/29/21 (039A21A) Moderna Dose 2 4/26/21 (048B21A) COVID Positive 1/4/22  1/13/22: Patient is a 71 year old male who presented to ED via EMS with complaints of generalized weakness. Patient has been vaccinated against COVID-19, did not receive his booster. He was seen in ED on 1/4 and tested positive for Covid-19. He was discharged home with the Covid home program. Per chart review the patient was contacted on 1/7 and stated he was "getting better" and would prefer not to participate in the program. Patient stated his symptoms worsened five days after testing positive for Covid. He has been experiencing extreme fatigue, nausea and diarrhea for the past 4 days.  He has been unable to tolerate food or fluids in the past 4 days. He has become progressively short of breath over the past several days. He has a past medical history of hypertension, borderline diabetes, and cirrhosis secondary to alcohol use.   On arrival to ED the patient was hypoxic on room air at 83%, 15 L OxyMask was applied on arrival to ED with improvement oxygen saturations, patient was weaned down to 10 L. laboratory findings were significant for mild hypokalemia 3.6.  Hyperglycemia 151.  Transaminitis AST 57 in ALP 151. Hyperbilirubinemia 1.4.  Lactic acidosis 3.9. PH 7.46 pCO2 32 PO2 67. D-dimer 3.41.  Chest x-ray shows interval worsening with diffuse multifocal bilateral airspace disease.  Azithromycin and ceftriaxone were initiated in ED.  Patient received DuoNeb treatment.  IV hydration was given with NS 0.9% 1 L.  1/20/22: 71-year-old male with no significant past medical history apart from alcohol abuse and liver cirrhosis who presented to the emergency department with shortness of breath admitted for COVID-19 pneumonia.  Pt was started on Rocephin and Zithromax, he received Actemra, no remdesivir due to liver cirrhosis, was on Lovenox twice a day, and Decadron.  Oxygen requirement were high initially but was successfully weaned down to 2 L by nasal cannula. Currently seems to be stable for discharge.  Will discharge to skilled nursing facility per PT/OT evaluation.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Fluid intake reduced, Hyperbilirubinaemia, Hyperglycaemia, Hypertransaminasaemia
Clinical narrative: Moderna Dose 1 3/29/21 (039A21A) Moderna Dose 2 4/26/21 (048B21A) COVID Positive 1/4/22  1/13/22: Patient is a 71 year old male who presented to ED via EMS with complaints of generalized weakness. Patient has been vaccinated against COVID-19, did not receive his booster. He was seen in ED on 1/4 and tested positive for Covid-19. He was discharged home with the Covid home program. Per chart review the patient was contacted on 1/7 and stated he was "getting better" and would prefer not to participate in the program. Patient stated his symptoms worsened five days after testing positive for Covid. He has been experiencing extreme fatigue, nausea and diarrhea for the past 4 days.  He has been unable to tolerate food or fluids in the past 4 days. He has become progressively short of breath over the past several days. He has a past medical history of hypertension, borderline diabetes, and cirrhosis secondary to alcohol use.   On arrival to ED the patient was hypoxic on room air at 83%, 15 L OxyMask was applied on arrival to ED with improvement oxygen saturations, patient was weaned down to 10 L. laboratory findings were significant for mild hypokalemia 3.6.  Hyperglycemia 151.  Transaminitis AST 57 in ALP 151. Hyperbilirubinemia 1.4.  Lactic acidosis 3.9. PH 7.46 pCO2 32 PO2 67. D-dimer 3.41.  Chest x-ray shows interval worsening with diffuse multifocal bilateral airspace disease.  Azithromycin and ceftriaxone were initiated in ED.  Patient received DuoNeb treatment.  IV hydration was given with NS 0.9% 1 L.  1/20/22: 71-year-old male with no significant past medical history apart from alcohol abuse and liver cirrhosis who presented to the emergency department with shortness of breath admitted for COVID-19 pneumonia.  Pt was started on Rocephin and Zithromax, he received Actemra, no remdesivir due to liver cirrhosis, was on Lovenox twice a day, and Decadron.  Oxygen requirement were high initially but was successfully weaned down to 2 L by nasal cannula. Currently seems to be stable for discharge.  Will discharge to skilled nursing facility per PT/OT evaluation.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokalaemia, Hypophagia, Hypoxia, Lactic acidosis, Lung disorder
Clinical narrative: Moderna Dose 1 3/29/21 (039A21A) Moderna Dose 2 4/26/21 (048B21A) COVID Positive 1/4/22  1/13/22: Patient is a 71 year old male who presented to ED via EMS with complaints of generalized weakness. Patient has been vaccinated against COVID-19, did not receive his booster. He was seen in ED on 1/4 and tested positive for Covid-19. He was discharged home with the Covid home program. Per chart review the patient was contacted on 1/7 and stated he was "getting better" and would prefer not to participate in the program. Patient stated his symptoms worsened five days after testing positive for Covid. He has been experiencing extreme fatigue, nausea and diarrhea for the past 4 days.  He has been unable to tolerate food or fluids in the past 4 days. He has become progressively short of breath over the past several days. He has a past medical history of hypertension, borderline diabetes, and cirrhosis secondary to alcohol use.   On arrival to ED the patient was hypoxic on room air at 83%, 15 L OxyMask was applied on arrival to ED with improvement oxygen saturations, patient was weaned down to 10 L. laboratory findings were significant for mild hypokalemia 3.6.  Hyperglycemia 151.  Transaminitis AST 57 in ALP 151. Hyperbilirubinemia 1.4.  Lactic acidosis 3.9. PH 7.46 pCO2 32 PO2 67. D-dimer 3.41.  Chest x-ray shows interval worsening with diffuse multifocal bilateral airspace disease.  Azithromycin and ceftriaxone were initiated in ED.  Patient received DuoNeb treatment.  IV hydration was given with NS 0.9% 1 L.  1/20/22: 71-year-old male with no significant past medical history apart from alcohol abuse and liver cirrhosis who presented to the emergency department with shortness of breath admitted for COVID-19 pneumonia.  Pt was started on Rocephin and Zithromax, he received Actemra, no remdesivir due to liver cirrhosis, was on Lovenox twice a day, and Decadron.  Oxygen requirement were high initially but was successfully weaned down to 2 L by nasal cannula. Currently seems to be stable for discharge.  Will discharge to skilled nursing facility per PT/OT evaluation.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, PCO2 decreased, PO2 decreased, SARS-CoV-2 test positive
Clinical narrative: Moderna Dose 1 3/29/21 (039A21A) Moderna Dose 2 4/26/21 (048B21A) COVID Positive 1/4/22  1/13/22: Patient is a 71 year old male who presented to ED via EMS with complaints of generalized weakness. Patient has been vaccinated against COVID-19, did not receive his booster. He was seen in ED on 1/4 and tested positive for Covid-19. He was discharged home with the Covid home program. Per chart review the patient was contacted on 1/7 and stated he was "getting better" and would prefer not to participate in the program. Patient stated his symptoms worsened five days after testing positive for Covid. He has been experiencing extreme fatigue, nausea and diarrhea for the past 4 days.  He has been unable to tolerate food or fluids in the past 4 days. He has become progressively short of breath over the past several days. He has a past medical history of hypertension, borderline diabetes, and cirrhosis secondary to alcohol use.   On arrival to ED the patient was hypoxic on room air at 83%, 15 L OxyMask was applied on arrival to ED with improvement oxygen saturations, patient was weaned down to 10 L. laboratory findings were significant for mild hypokalemia 3.6.  Hyperglycemia 151.  Transaminitis AST 57 in ALP 151. Hyperbilirubinemia 1.4.  Lactic acidosis 3.9. PH 7.46 pCO2 32 PO2 67. D-dimer 3.41.  Chest x-ray shows interval worsening with diffuse multifocal bilateral airspace disease.  Azithromycin and ceftriaxone were initiated in ED.  Patient received DuoNeb treatment.  IV hydration was given with NS 0.9% 1 L.  1/20/22: 71-year-old male with no significant past medical history apart from alcohol abuse and liver cirrhosis who presented to the emergency department with shortness of breath admitted for COVID-19 pneumonia.  Pt was started on Rocephin and Zithromax, he received Actemra, no remdesivir due to liver cirrhosis, was on Lovenox twice a day, and Decadron.  Oxygen requirement were high initially but was successfully weaned down to 2 L by nasal cannula. Currently seems to be stable for discharge.  Will discharge to skilled nursing facility per PT/OT evaluation.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Malaise, Pyrexia
Clinical narrative: Patient seen in the emergency department on 5/30 for generalized weakness, rigors, fever, cough, and malaise. She has medical history of CKD. Patient admitted to the hospital from 5/30-6/4. This meets criteria for VAERS reporting.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, Nasopharyngitis, Pain, SARS-CoV-2 test positive
Clinical narrative: I had body aches after the vaccine which lasted about 12 hours. I began to feel bad like a bad cold on June 19. I tested for COVID-19 on June 20 and it was positive.  I contacted my primary care doctor and she prescribed Paxolovid.  Prior to contacted my doctor, I took something for allergies.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: Client given a 2nd booster but does not meet current requirements for second booster.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Blood creatinine increased, Blood culture positive, COVID-19
Clinical narrative: J&J Dose 5/10/21 (lot NA) COVID Positive 1/6/22 (pt reported) COVID Positive 1/20/22  1/20/22: Patient is a 76-year-old male with significant past medical history of diabetes mellitus type 2 - on insulin, coronary artery disease, systolic CHF - pacemaker ICD, paroxysmal atrial fibrillation - on Eliquis, non-Hodgkin's lymphoma, CKD 3B and obstructive sleep apnea. Patient is a nonsmoker nonalcoholic.  Lives with his wife. Able to ambulate without any assistive device .  Able to do all ADLs. Part-time he live in another area.  Recently patient started experiencing exertional shortness of breath, sore throat, dry cough, nasal congestion and stuffiness - upper respiratory like symptoms.  Appetite greatly reduced. Denies nausea vomiting chest pain fever or chills. On January 6th - he was diagnosed with COVID.  He was supposed to get antibody infusion. Patient decided to come here.  His wife drove.   In the emergency room evaluation - at rest, on room air he is saturating 90%.  With minimal activity, desaturating to 85%.  He had no home oxygen dependency.  Baseline creatinine 1.6 worsened to 2.37.  Chest x-ray shows bilateral infiltrates.  Fever 100.7. Influenza a and B negative.  D-dimer normal. With suspicion of superimposed bacterial pneumonia, in ER he  received Rocephin and azithromycin.   I examined patient in emergency room.  Patient is slightly anxious. Answering questions appropriately.  Patient denies having any chest pain, fever or diarrhea.  Said last 3 nights he experiences significant night sweats. Complains of generalized weakness. Discussed with patient about treatment options. Per hospital policy with GFR less than 30, remdesivir is not an option. Will hold diuretic and gently hydrate.  Recheck renal panel in a.m.  If GFR improve, can start on remdesivir.  Ordering Actemra. Patient had history of systolic congestive heart failure.  1/25/22: 76-year-old male with a history of T2 dm on insulin, CAD, systolic CHF, status post AICD placement, PAF on Eliquis, NHL, CKD 3B, morbid obesity and OSA.   He was admitted for acute hypoxia secondary to COVID-19 infection. He was initially diagnosed with COVID-19 on 01/06/2022.  He has been improving with gradual improvement in oxygenation. At this morning he is down to room air with O2 saturation of 94-95%.  He had an oxygen walk for home determination and requires no supplemental oxygen.  Two sets of blood cultures done on admission were positive for coagulase negative Staph but repeat blood culture x2 came back negative indicating the initial positive was a contaminant. He will be discharged on his pre-admission medications.  He will enroll in COVID safe at home program in the meantime.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Cough, Decreased appetite, Dyspnoea, Dyspnoea exertional
Clinical narrative: J&J Dose 5/10/21 (lot NA) COVID Positive 1/6/22 (pt reported) COVID Positive 1/20/22  1/20/22: Patient is a 76-year-old male with significant past medical history of diabetes mellitus type 2 - on insulin, coronary artery disease, systolic CHF - pacemaker ICD, paroxysmal atrial fibrillation - on Eliquis, non-Hodgkin's lymphoma, CKD 3B and obstructive sleep apnea. Patient is a nonsmoker nonalcoholic.  Lives with his wife. Able to ambulate without any assistive device .  Able to do all ADLs. Part-time he live in another area.  Recently patient started experiencing exertional shortness of breath, sore throat, dry cough, nasal congestion and stuffiness - upper respiratory like symptoms.  Appetite greatly reduced. Denies nausea vomiting chest pain fever or chills. On January 6th - he was diagnosed with COVID.  He was supposed to get antibody infusion. Patient decided to come here.  His wife drove.   In the emergency room evaluation - at rest, on room air he is saturating 90%.  With minimal activity, desaturating to 85%.  He had no home oxygen dependency.  Baseline creatinine 1.6 worsened to 2.37.  Chest x-ray shows bilateral infiltrates.  Fever 100.7. Influenza a and B negative.  D-dimer normal. With suspicion of superimposed bacterial pneumonia, in ER he  received Rocephin and azithromycin.   I examined patient in emergency room.  Patient is slightly anxious. Answering questions appropriately.  Patient denies having any chest pain, fever or diarrhea.  Said last 3 nights he experiences significant night sweats. Complains of generalized weakness. Discussed with patient about treatment options. Per hospital policy with GFR less than 30, remdesivir is not an option. Will hold diuretic and gently hydrate.  Recheck renal panel in a.m.  If GFR improve, can start on remdesivir.  Ordering Actemra. Patient had history of systolic congestive heart failure.  1/25/22: 76-year-old male with a history of T2 dm on insulin, CAD, systolic CHF, status post AICD placement, PAF on Eliquis, NHL, CKD 3B, morbid obesity and OSA.   He was admitted for acute hypoxia secondary to COVID-19 infection. He was initially diagnosed with COVID-19 on 01/06/2022.  He has been improving with gradual improvement in oxygenation. At this morning he is down to room air with O2 saturation of 94-95%.  He had an oxygen walk for home determination and requires no supplemental oxygen.  Two sets of blood cultures done on admission were positive for coagulase negative Staph but repeat blood culture x2 came back negative indicating the initial positive was a contaminant. He will be discharged on his pre-admission medications.  He will enroll in COVID safe at home program in the meantime.